10-K Filing

Xenetic Biosciences, Inc. CIK: 1534525 FY 2014

Filing Information

Form Type	10-K
Accession Number	`0001019687-15-001465`
Period End Date	20141231
Filing Date	20150415
Fiscal Year	2014
Fiscal Period	FY
XBRL Instance	xbio-20141231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 38 Cash Flow Statement 60 Stockholders Equity 18

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	215.46M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	215.46M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	130.58M	shares	Point-in-time
Cash	`Cash`	$4.84M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	149.99M	shares	Point-in-time
Cash	`Cash`	$11.14M	USD	Point-in-time
Cash	`Cash`	$2.51M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	139.30M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	119.89M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$66.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$66.00K	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$115.78K	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$256.01K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$168.31K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$88.24K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.33M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.78M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$152.60K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$119.45K	USD	Point-in-time
Goodwill	`Goodwill`	$3.59M	USD	Point-in-time
Goodwill	`Goodwill`	$3.67M	USD	Point-in-time
Goodwill	`Goodwill`	$3.47M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$10.32M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.75M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$199.27K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Total assets	`Assets`	$19.47M	USD	Point-in-time
Total assets	`Assets`	$16.32M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$852.76K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$942.16K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.41M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.83M	USD	Point-in-time
Accrued payroll taxes	`AccruedPayrollTaxesCurrent`	-	USD	Point-in-time
Accrued payroll taxes	`AccruedPayrollTaxesCurrent`	$84.60K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$41.47K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$55.27K	USD	Point-in-time
Loans due to related parties	`DueToRelatedPartiesCurrent`	$395.00K	USD	Point-in-time
Loans due to related parties	`DueToRelatedPartiesCurrent`	$681.12K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.59M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.70M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$3.26M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$3.08M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$56.38K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$6.85M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.84M	USD	Point-in-time
Common stock, $0.01 par value; 215,456,000 shares authorized as of December 31, 2014 and 2013; 149,985,476 and 130,575,516 shares issued as of December 31, 2014 and 2013, respectively; 139,297,282 and 119,887,322 shares outstanding as of December 31, 2014 and 2013, respectively	`CommonStockValue`	$1.31M	USD	Point-in-time
Common stock, $0.01 par value; 215,456,000 shares authorized as of December 31, 2014 and 2013; 149,985,476 and 130,575,516 shares issued as of December 31, 2014 and 2013, respectively; 139,297,282 and 119,887,322 shares outstanding as of December 31, 2014 and 2013, respectively	`CommonStockValue`	$1.50M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$89.31M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$74.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-58.31M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-75.62M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$575.68K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$900.25K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.48M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.78M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.62M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$16.32M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.47M	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	Annual
Revenue	`Revenues`	$1.00M	USD	Annual
Cost of revenue	`CostOfRevenue`	-	USD	Annual
Cost of revenue	`CostOfRevenue`	-	USD	Annual
Gross profit	`GrossProfit`	$1.00M	USD	Annual
Gross profit	`GrossProfit`	-	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$6.32M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.08M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.60M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.46M	USD	Annual
Total operating costs and expenses	`OperatingExpenses`	$12.92M	USD	Annual
Total operating costs and expenses	`OperatingExpenses`	$9.55M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-8.55M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-12.92M	USD	Annual
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	$-1.07M	USD	Annual
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	-	USD	Annual
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-66.18K	USD	Annual
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-326.92K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$18.96K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$34.85K	USD	Annual
Interest expense	`InterestExpense`	$4.71K	USD	Annual
Interest expense	`InterestExpense`	$632.00	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-31.95K	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-1.38M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.58M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-14.31M	USD	Annual
Income tax	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income tax	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-14.31M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.58M	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-15.34K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-324.58K	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-14.63M	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.59M	USD	Annual
Net loss per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.11	USD	Annual
Net loss per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	Annual
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	119.83M	shares	Annual
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	135.90M	shares	Annual

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-14.31M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.58M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$52.03K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$88.69K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$702.04K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$431.50K	USD	Annual
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	$-1.07M	USD	Annual
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	-	USD	Annual
Fee paid on disposal of subsidiaries	`FeePaidOnDisposalOfSubsidiaries`	-	USD	Annual
Fee paid on disposal of subsidiaries	`FeePaidOnDisposalOfSubsidiaries`	$-430.00K	USD	Annual
Non-cash issuance of common stock	`OtherNoncashExpense`	-	USD	Annual
Non-cash issuance of common stock	`OtherNoncashExpense`	$811.20K	USD	Annual
Non-cash issuance of warrants	`NoncashIssuanceOfWarrants`	-	USD	Annual
Non-cash issuance of warrants	`NoncashIssuanceOfWarrants`	$239.89K	USD	Annual
Foreign currency translation	`ForeignCurrencyTransactionGainLossBeforeTax`	-	USD	Annual
Foreign currency translation	`ForeignCurrencyTransactionGainLossBeforeTax`	$14.96K	USD	Annual
Accounts receivable, prepayments and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$7.52K	USD	Annual
Accounts receivable, prepayments and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$24.47K	USD	Annual
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-479.01K	USD	Annual
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.07M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-12.33M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-6.05M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$78.63K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$57.67K	USD	Annual
Disposition of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Disposition of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$5.49K	USD	Annual
Cash acquired from Acquisition	`CashAcquiredFromAcquisition`	-	USD	Annual
Cash acquired from Acquisition	`CashAcquiredFromAcquisition`	$43.50K	USD	Annual
Cash transferred in connection with Hive Out Agreement	`CashDivestedFromDeconsolidation`	-	USD	Annual
Cash transferred in connection with Hive Out Agreement	`CashDivestedFromDeconsolidation`	$43.50K	USD	Annual
Change in restricted cash	`IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities`	$66.00K	USD	Annual
Change in restricted cash	`IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-144.63K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-52.18K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$10.00M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.09K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$101.93K	USD	Annual
Payments on loan from related party	`RepaymentsOfRelatedPartyDebt`	$286.12K	USD	Annual
Payments on loan from related party	`RepaymentsOfRelatedPartyDebt`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.09K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$9.82M	USD	Annual
Effect of exchange rate change on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-102.82K	USD	Annual
Effect of exchange rate change on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$233.38K	USD	Annual
Net decrease in cash and cash equivalents, excluding restricted cash	`CashPeriodIncreaseDecrease`	$-6.30M	USD	Annual
Net decrease in cash and cash equivalents, excluding restricted cash	`CashPeriodIncreaseDecrease`	$-2.33M	USD	Annual
Cash and cash equivalents at beginning of period	`Cash`	$4.84M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`Cash`	$11.14M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`Cash`	$2.51M	USD	Point-in-time
Cash and cash equivalents at end of period	`Cash`	$4.84M	USD	Point-in-time
Cash and cash equivalents at end of period	`Cash`	$11.14M	USD	Point-in-time
Cash and cash equivalents at end of period	`Cash`	$2.51M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	Annual
Cash paid for interest	`InterestPaidNet`	$4.71K	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Equity consideration transferred in the Acquisition	`BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable`	-	USD	Annual
Equity consideration transferred in the Acquisition	`BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable`	$3.75M	USD	Annual
Repurchase and cancellation of common stock in disposal of subsidiaries	`StockRepurchasedAndRetiredDuringPeriodValue`	-	USD	Annual
Repurchase and cancellation of common stock in disposal of subsidiaries	`StockRepurchasedAndRetiredDuringPeriodValue`	$3.75M	USD	Annual

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$10.48M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$20.78M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$12.62M	USD	Point-in-time
Exercise of stock options, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.09K	USD	Annual
Exercise of stock options, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$101.93K	USD	Annual
Issuance of common stock	`StockIssuedDuringPeriodValueNewIssues`	$10.81M	USD	Annual
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$239.89K	USD	Annual
Deemed issuance of shares in reverse merger	`StockIssuedDuringPeriodValueAcquisitions`	$3.75M	USD	Annual
Repurchase and cancellation of shares in Hive Out Agreement	`RepurchaseAndCancellationOfSharesInHiveOutAgreement`	$3.11M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$431.50K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$702.04K	USD	Annual
Net loss	`NetIncomeLoss`	$-14.31M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.58M	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-15.34K	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-324.58K	USD	Annual
Ending balance, value	`StockholdersEquity`	$10.48M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$20.78M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$12.62M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.